These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33208122)

  • 21. Lack of association between ABCC2 gene variants and treatment response in epilepsy.
    Hilger E; Reinthaler EM; Stogmann E; Hotzy C; Pataraia E; Baumgartner C; Zimprich A; Zimprich F
    Pharmacogenomics; 2012 Jan; 13(2):185-90. PubMed ID: 22256867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL28B rs12979860 gene polymorphism in Egyptian patients with chronic liver disease infected with HCV.
    Zekri AR; Salama H; Medhat E; Bahnassy AA; Morsy HM; Lotfy MM; Ahmed R; Darwish T; Marei MS
    Asian Pac J Cancer Prev; 2014; 15(17):7213-8. PubMed ID: 25227816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRP2 haplotypes confer differential susceptibility to toxic liver injury.
    Choi JH; Ahn BM; Yi J; Lee JH; Lee JH; Nam SW; Chon CY; Han KH; Ahn SH; Jang IJ; Cho JY; Suh Y; Cho MO; Lee JE; Kim KH; Lee MG
    Pharmacogenet Genomics; 2007 Jun; 17(6):403-15. PubMed ID: 17502832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary liver carcinoma in genetic hemochromatosis reveals a broad histologic spectrum.
    Morcos M; Dubois S; Bralet MP; Belghiti J; Degott C; Terris B
    Am J Clin Pathol; 2001 Nov; 116(5):738-43. PubMed ID: 11710692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined Hepatocellular-Cholangiocarcinoma in a Patient With Cirrhosis Due to Cholesteryl Ester Storage Disease.
    Castro Narro GE; Gamboa Domínguez A; Consuelo Sánchez A; Salazar Martínez A; Agramonte Hevia J; Cebolla JJ; Cuellar Mendoza ME; Díaz Hernández HA
    Hepatology; 2019 Apr; 69(4):1838-1841. PubMed ID: 30372535
    [No Abstract]   [Full Text] [Related]  

  • 26. IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC.
    Fabris C; Falleti E; Cussigh A; Bitetto D; Fontanini E; Bignulin S; Cmet S; Fornasiere E; Fumolo E; Fangazio S; Cerutti A; Minisini R; Pirisi M; Toniutto P
    J Hepatol; 2011 Apr; 54(4):716-22. PubMed ID: 21146242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
    Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
    Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No increased risk of hepatocellular carcinoma in cirrhosis due to Wilson disease during long-term follow-up.
    van Meer S; de Man RA; van den Berg AP; Houwen RH; Linn FH; van Oijen MG; Siersema PD; van Erpecum KJ
    J Gastroenterol Hepatol; 2015 Mar; 30(3):535-9. PubMed ID: 25160780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inducible liver-specific overexpression of gankyrin in zebrafish results in spontaneous intrahepatic cholangiocarcinoma and hepatocellular carcinoma formation.
    Huang SJ; Cheng CL; Chen JR; Gong HY; Liu W; Wu JL
    Biochem Biophys Res Commun; 2017 Aug; 490(3):1052-1058. PubMed ID: 28668389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma.
    Joseph NM; Tsokos CG; Umetsu SE; Shain AH; Kelley RK; Onodera C; Bowman S; Talevich E; Ferrell LD; Kakar S; Krings G
    J Pathol; 2019 Jun; 248(2):164-178. PubMed ID: 30690729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular diagnosis of Wilson disease using prevalent mutations and informative single-nucleotide polymorphism markers.
    Gupta A; Maulik M; Nasipuri P; Chattopadhyay I; Das SK; Gangopadhyay PK; ; Ray K
    Clin Chem; 2007 Sep; 53(9):1601-8. PubMed ID: 17634212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Somatic changes in primary liver cancer in Russia: a pilot study.
    Kalinina O; Marchio A; Urbanskii AI; Tarkova AB; Rebbani K; Granov DA; Dejean A; Generalov MI; Pineau P
    Mutat Res; 2013 Aug; 755(2):90-9. PubMed ID: 23830926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic variation in the ABCC2 gene is associated with dose decreases or switches to other cholesterol-lowering drugs during simvastatin and atorvastatin therapy.
    Becker ML; Elens LL; Visser LE; Hofman A; Uitterlinden AG; van Schaik RH; Stricker BH
    Pharmacogenomics J; 2013 Jun; 13(3):251-6. PubMed ID: 22186618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer.
    Han JY; Lim HS; Yoo YK; Shin ES; Park YH; Lee SY; Lee JE; Lee DH; Kim HT; Lee JS
    Cancer; 2007 Jul; 110(1):138-47. PubMed ID: 17534875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations in DNA Damage Repair Genes in Primary Liver Cancer.
    Lin J; Shi J; Guo H; Yang X; Jiang Y; Long J; Bai Y; Wang D; Yang X; Wan X; Zhang L; Pan J; Hu K; Guan M; Huo L; Sang X; Wang K; Zhao H
    Clin Cancer Res; 2019 Aug; 25(15):4701-4711. PubMed ID: 31068370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
    Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
    Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis.
    Tanabe KK; Lemoine A; Finkelstein DM; Kawasaki H; Fujii T; Chung RT; Lauwers GY; Kulu Y; Muzikansky A; Kuruppu D; Lanuti M; Goodwin JM; Azoulay D; Fuchs BC
    JAMA; 2008 Jan; 299(1):53-60. PubMed ID: 18167406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosis.
    Nahon P; Zucman-Rossi J
    J Hepatol; 2012 Sep; 57(3):663-74. PubMed ID: 22609306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comprehensive functional and clinical analysis of ABCC2 and its impact on treatment response to carbamazepine.
    Rädisch S; Dickens D; Lang T; Bonnett L; Arlanov R; Johnson MR; Schwab M; Marson AG; Pirmohamed M
    Pharmacogenomics J; 2014 Oct; 14(5):481-7. PubMed ID: 24567120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spectrum of mutations in the ATP binding domain of ATP7B gene of Wilson Disease in a regional Indian cohort.
    Guggilla SR; Senagari JR; Rao PN; Madireddi S
    Gene; 2015 Sep; 569(1):83-7. PubMed ID: 25982861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.